These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 30899428)

  • 1. Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.
    Carter P; Alifrangis C; Chandrasinghe P; Cereser B; Del Bel Belluz L; Leo CA; Moderau N; Tabassum N; Warusavitarne J; Krell J; Stebbing J
    Oncotarget; 2018 Mar; 9(19):15165. PubMed ID: 29601069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
    Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
    Oncotarget; 2017 Mar; 8(12):19902-19913. PubMed ID: 28423634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
    Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
    Oncotarget; 2018 Apr; 9(25):17979. PubMed ID: 29707163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements.
    Dong J; Toh HJ; Thong PS; Tee CS; Bi R; Soo KC; Lee K
    J Photochem Photobiol B; 2014 Nov; 140():163-72. PubMed ID: 25146878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.
    Zhang N; Kong L; Shi F; Jing W; Wang H; Yang M; Yu J; Zhu H
    Oncotarget; 2017 Dec; 8(66):110732. PubMed ID: 29300397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
    Cedena MT; Rapado I; Santos-Lozano A; Ayala R; Onecha E; Abaigar M; Such E; Ramos F; Cervera J; Díez-Campelo M; Sanz G; Rivas JH; Lucía A; Martínez-López J
    Oncotarget; 2018 Jul; 9(56):30936. PubMed ID: 30112119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
    Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
    Oncotarget; 2019 Feb; 10(16):1602. PubMed ID: 30899428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Resolved Diffuse Optical Spectroscopy and Imaging Using Solid-State Detectors: Characteristics, Present Status, and Research Challenges.
    Alayed M; Deen MJ
    Sensors (Basel); 2017 Sep; 17(9):. PubMed ID: 28906462
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.